Anethole, a chief constituent of anise,
camphor, and fennel, has been shown to block both
inflammation and
carcinogenesis, but just how these effects are mediated is not known. One possibility is TNF-mediated signaling, which has also been associated with both
inflammation and
carcinogenesis. In the present report we show that
anethole is a potent inhibitor of TNF-induced
NF-kappaB activation (an early response) as monitored by electrophoretic mobility shift assay,
IkappaBalpha phosphorylation and degradation, and
NF-kappaB reporter gene expression. Suppression of
IkappaBalpha phosphorylation and
NF-kappaB reporter gene expression induced by
TRAF2 and NIK, suggests that
anethole acts on
IkappaBalpha kinase.
Anethole also blocked the
NF-kappaB activation induced by a variety of other inflammatory agents. Besides
NF-kappaB,
anethole also suppressed TNF-induced activation of the
transcription factor AP-1,
c-jun N-terminal kinase and
MAPK-kinase. In addition,
anethole abrogated TNF-induced apoptosis as measured by both
caspase activation and cell viability. The
anethole analogues
eugenol and
isoeugenol also blocked TNF signaling.
Anethole suppressed TNF-induced both lipid peroxidation and ROI generation. Overall, our results demonstrate that
anethole inhibits TNF-induced cellular responses, which may explain its role in suppression of
inflammation and
carcinogenesis. Oncogene (2000).